{"id":"NCT04321460","sponsor":"Sandoz","briefTitle":"Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.","officialTitle":"Multicentre, Double-blind, Randomized, Placebo-controlled, Parallel-group Efficacy and Safety Study of LRG-002 Hard Capsules (Lek d.d., Slovenia) Used in the Prophylaxis of Antibiotic-associated Diarrhea in Adults.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-10-01","primaryCompletion":"2021-01-04","completion":"2021-01-04","firstPosted":"2020-03-25","resultsPosted":"2022-03-14","lastUpdate":"2022-03-14"},"enrollment":520,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Antibiotic-associated Diarrhea"],"interventions":[{"type":"DRUG","name":"LRG-002","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"LRG-002","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The goal of this study was to investigate the efficacy and safety of LRG-002 investigational medicinal product, capsules (Lek d.d., Slovenia) in comparison with placebo, as an adjunct treatment for prophylaxis of antibiotic-associated diarrhea (AAD) in patients with acute respiratory diseases (ARDs) receiving a standard antimicrobial therapy.","primaryOutcome":{"measure":"Number of Participants With the Occurrence of Antibiotic-associated Diarrhea (AAD) - Per Protocol (PP) Population","timeFrame":"14 days","effectByArm":[{"arm":"LRG-002","deltaMin":4,"sd":null},{"arm":"Placebo","deltaMin":17,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.007"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":3,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":260},"commonTop":["Decreased appetite","Flatulence","Abdominal pain","Nausea","Diarrhea"]}}